AIM
AGN

Advantage Investment Management’s Allergan Inc AGN Stock Holding History

Advantage Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-297
Closed -$88K – 951
2015
Q1 		$88K Sell
297
-154
-34% -$34.8K 0.05% 263
2014
Q4 		$116K Buy
+451
New +$89.7K 0.09% 188

Other funds holding AGN

MAM
Mark Asset Management New York $1.49B AUM 68.19% 1-Year Est. Return
NAMP
NorthStar Asset Management (Pennsylvania) Blue Bell, Pennsylvania $531M AUM 27.28% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $160M AUM 15.21% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $461M AUM 43.48% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
AAC
Asset Advisors Corp Augusta, Georgia $575M AUM 14.42% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return

Advantage Investment Management's AGN Position: Q2 2015 in Review

Advantage Investment Management sold out of Allergan Inc (AGN) in Q2 2015, closing a stake of 297 shares — an estimated $88K sold.

Advantage Investment Management first reported a position in AGN in Q4 2014 and held it in 2 quarters. The position peaked at $116K in Q4 2014. 35 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Advantage Investment Management reported no remaining Allergan Inc position as of Q2 2015 after selling out during the quarter.
  • Advantage Investment Management sold 297 Allergan Inc shares in Q2 2015, an estimated $88K.
  • Advantage Investment Management first reported a position in Allergan Inc in Q4 2014 and held it in 2 quarters.
  • Advantage Investment Management's Allergan Inc position peaked at $116K in Q4 2014.
  • 35 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2015.

Based on Advantage Investment Management's 13F filing for Q2 2015, filed 27 Mar 2017.